These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure. Williamson J; Eilon LA; Walker SR Trans Ophthalmol Soc U K (1962); 1981; 101(1):27-9. PubMed ID: 6764318 [TBL] [Abstract][Full Text] [Related]
7. Relation between office intraocular pressure and 24-hour intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops. Nakakura S; Nomura Y; Ataka S; Shiraki K J Glaucoma; 2007 Mar; 16(2):201-4. PubMed ID: 17473730 [TBL] [Abstract][Full Text] [Related]
8. [The effect of timolol eye drops on the intraocular pressure in simple glaucoma (author's transl)]. Krieglstein GK Klin Monbl Augenheilkd; 1978 May; 172(5):677-85. PubMed ID: 672089 [TBL] [Abstract][Full Text] [Related]
9. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448 [TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome. Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259 [TBL] [Abstract][Full Text] [Related]
12. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Tamer C; Oksüz H Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574 [TBL] [Abstract][Full Text] [Related]
13. [Experiences in a double-blind study with different concentrations of timolol and pilocarpine (author's transl)]. Merté HJ; Merkle W Klin Monbl Augenheilkd; 1980 Oct; 177(4):443-50. PubMed ID: 7019558 [TBL] [Abstract][Full Text] [Related]
14. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study. Martínez A; Sánchez M Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468 [TBL] [Abstract][Full Text] [Related]
15. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials. Varma R; Hwang LJ; Grunden JW; Bean GW Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194 [TBL] [Abstract][Full Text] [Related]
16. Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma. Aung T; Chan YH; Chew PT; Ophthalmology; 2005 Feb; 112(2):267-71. PubMed ID: 15691562 [TBL] [Abstract][Full Text] [Related]
17. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension. Chiba T; Kashiwagi K; Chiba N; Tsukahara S Br J Ophthalmol; 2006 Mar; 90(3):314-7. PubMed ID: 16488953 [TBL] [Abstract][Full Text] [Related]
18. [The effect of low concentrations of pilocarpine with phenylephrine on intraocular pressure in glaucoma (author's transl)]. Leydhecker W; Krieglstein GK Klin Monbl Augenheilkd; 1978 Oct; 173(4):533-6. PubMed ID: 366257 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of long-term maintenance treatment with timolol ophthalmic solution in chronic open-angle glaucoma (author's transl)]. Katz IM Klin Monbl Augenheilkd; 1979 Aug; 175(2):225-31. PubMed ID: 392172 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension. Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]